A strong stock as of late has been CVS Health (CVS) . Shares have been marching higher, with the stock up 8.4% over the past month. The stock hit a new 52-week high of $79.94 in the previous session. CVS Health has gained 77.5% since the start of the year compared to the 0.2% gain for the Zacks Medical sector and the -0% return for the Zacks Medical Services industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensu ...

VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has completed its previously announced name change to Algernon Health Inc. The Company’s common shares will begin trading under the new name on the CSE at market-open on Monday, October 20, 2025. The common shares will trade under the new name with a new CUSIP number, but the stock symbol will r ...

新华 来自30个省份的85家医疗机构12日在北京联合成立全国儿童青少年精神心理科联盟,旨在进一步构建起 呵护"小心灵"的精神卫生服务体系。该联盟由北京大学第六医院牵头,成员单位涵盖了多地开设有儿童 青少年精神心理科的精神专科医院、综合医院、儿童医院、妇幼保健院。 ...

InnovAge Holding Corp. (INNV) shares ended the last trading session 8.6% higher at $5.55. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.3% gain over the past four weeks.InnovAge Holding Corp. scored a strong price increase, on investors’ optimism surrounding its impending fiscal 2026 first-quarter financial results, which is expected to release next month. The Zacks Consensus Estimate for the first quarter rev ...

The Medical Services sector is undergoing a rapid transformation driven by advances in digital health, wider adoption of value-based care and a stronger focus on patient-centric and precision medicine solutions. Demand for remote treatment continues to accelerate growth in telemedicine and AI-powered analytics, with providers using these tools to improve diagnostics, streamline operations and deliver more personalized, preventive care. According to a Precedence Research report, the global healthcare analyti ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering BrightSpring Health Services, Inc. (BTSG) , which belongs to the Zacks Medical Services industry.When looking at the last two reports, this company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 76.64%, on average, in the last two quarters.For the last reported quarter, BrightSpring Health Services, Inc. cam ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Medpace (MEDP) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Medpace is a member of the Medical sector. This group includes 957 individual stocks and currently holds a Za ...

Organon (OGN) closed the most recent trading day at $10.84, moving -1.54% from the previous trading session. This move lagged the S&P 500's daily gain of 0.37%. Elsewhere, the Dow saw a downswing of 0.14%, while the tech-heavy Nasdaq appreciated by 0.71%. Heading into today, shares of the pharmaceutical company had gained 6.07% over the past month, outpacing the Medical sector's gain of 5.9% and the S&P 500's gain of 4.26%.Investors will be eagerly watching for the performance of Organon in its upcoming ear ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock characte ...

Core Viewpoint - Pediatrix Medical Group (MD) has shown strong stock performance, with a 33.4% increase since the beginning of the year, outperforming the Zacks Medical sector and Zacks Medical Services industry [1][2] Financial Performance - The company has consistently beaten earnings estimates, reporting an EPS of $0.53 against a consensus estimate of $0.42 in its last earnings report [2] - For the current fiscal year, Pediatrix is expected to post earnings of $1.78 per share on revenues of $1.89 billion, reflecting a 17.88% increase in EPS but a 6.3% decrease in revenues [3] - The next fiscal year projections indicate earnings of $1.80 per share on revenues of $1.94 billion, showing a year-over-year change of 1.12% in EPS and 2.63% in revenues [3] Valuation Metrics - Pediatrix Medical Group has a Value Score of A, a Growth Score of A, and a Momentum Score of F, resulting in a combined VGM Score of A [6] - The stock trades at 9.8X current fiscal year EPS estimates, significantly lower than the peer industry average of 17.4X, indicating strong value potential [7] - On a trailing cash flow basis, the stock trades at 9.9X compared to the peer group's average of 10.2X, positioning it favorably for value investors [7] Zacks Rank - The company holds a Zacks Rank of 1 (Strong Buy), driven by rising earnings estimates, making it an attractive option for investors [8][9] Industry Comparison - Compared to industry peers, Charles River Laboratories International, Inc. (CRL) also shows strong performance with a Zacks Rank of 2 (Buy) and solid earnings expectations [10][11] - CRL is expected to post earnings of $10.11 per share on revenues of $3.97 billion for the current fiscal year, with shares gaining 8.1% over the past month [11][12]